Host: Scott Kopetz, MD, PhD 

 Host: Cathy Eng, MD, FACP 


 
 This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.

Host: Scott Kopetz, MD, PhD Host: Cathy Eng, MD, FACP This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.

Host: Scott Kopetz, MD, PhD 

 Host: Cathy Eng, MD, FACP 


 
 This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.

Share Case Consult: Current Standards and Emerging Directions in BRAF-Mutant mCRC Care

Sign up to save your podcasts

Case Consult: Current Standards and Emerging Directions in BRAF-Mutant mCRC Care

Case Consult: Current Standards and Emerging Directions in BRAF-Mutant mCRC Care